Thus, whereas the relative overexpression of livin in renal cell carcinoma indicates that it may still represent a therapeutic target to increase the apoptotic sensitivity of kidney cancer cells, this strategy is likely to be not tumour-specific. The gene discussed is BIRC7; the disease is hereditary clear cell renal cell carcinoma.